HOLLY KOLLMAN: Open Payments
NPI 1790144384 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 10 payments from 7 companies in 2025. Trend: 2023 $604 · 2024 $548 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $115 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $32 |
| ARGENX US, INC. | 1 | $28 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $18 |
Products named: ENTYVIO, ONPATTRO, SKYRIZI, VYVGART HYTRULO, LEQVIO, VYEPTI, COSENTYX.
Industry payments across OH — which companies pay providers there.
